Arkolith/Insider Trading/IOVA/Form 4

Maynard Ryan D

DirectorIOVANCE BIOTHERAPEUTICS, INC. (IOVA) · full profile →Form 4 · filed Nov 14, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$503K
Net Open-Market Flow
-$503K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2024Sell(S)50K$10.06$503K8K
Nov 12, 2024Option exercise(M)50K$7.45$373K58K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 12, 2024Option exercise(M)50K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-119195) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for IOVANCE BIOTHERAPEUTICS, INC.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp